NASDAQ:ODT
Odonate Therapeutics, Inc.
- Stock
Last Close
1.17
01/01 00:00
Volume Today
716.44K
Avg: 959.82K
PE Ratio
−0.29
PFCF: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | ||
---|---|---|---|---|---|---|---|
average inventory | |||||||
average payables | 300.50K - | 2.44M 710.98% | 7.54M 209.38% | 13.18M 74.81% | 14.88M 12.86% | ||
average receivables | |||||||
book value per share | 0.00 - | 0.08 1,956.76% | 13.83 16,191.21% | 5.07 63.35% | 5.88 15.90% | 4.15 29.40% | |
capex per share | -0.01 - | -0.08 1,230.85% | -0.01 92.29% | -0.01 119.04% | |||
capex to depreciation | -4.15 - | -5.45 31.29% | -0.44 92.00% | -0.97 122.81% | |||
capex to operating cash flow | 0.00 - | 0.03 785.49% | 0.00 93.96% | 0.00 122.30% | |||
capex to revenue | |||||||
cash per share | 0.01 - | 0.10 1,783.33% | 13.98 14,365.46% | 5.68 59.34% | 6.53 14.92% | 4.79 26.65% | |
days of inventory on hand | |||||||
days payables outstanding | |||||||
days sales outstanding | |||||||
debt to assets | 0.21 - | 0.21 0.20% | 0.04 82.22% | 0.13 254.47% | 0.14 7.36% | 0.19 34.58% | |
debt to equity | 0.26 - | 0.26 0.26% | 0.04 85.37% | 0.15 292.78% | 0.16 8.56% | 0.23 42.64% | |
dividend yield | 0.00 - | ||||||
earnings yield | -0.00 - | -0.00 1,852.53% | -0.09 1,753.14% | -0.26 179.42% | -0.12 51.70% | -0.20 60.73% | |
enterprise value | 618.34M - | 615.88M 0.40% | 156.13M 74.65% | 205.38M 31.54% | 718.05M 249.62% | 478.24M 33.40% | |
enterprise value over ebitda | -3.91K - | -199.64 94.90% | -4.77 97.61% | -2.32 51.42% | -6.44 177.99% | -3.80 41.05% | |
ev to operating cash flow | -3.75K - | -355.38 90.52% | -6.04 98.30% | -3.06 49.30% | -7.43 142.74% | -4.23 43.11% | |
ev to sales | |||||||
free cash flow per share | -0.01 - | -0.06 950.30% | -1.83 2,740.74% | -2.82 54.07% | -3.50 24.23% | -3.46 1.26% | |
free cash flow yield | -0.00 - | -0.00 950.30% | -0.07 2,513.48% | -0.20 173.57% | -0.11 46.10% | -0.18 66.88% | |
graham net net | 0.00 - | 0.07 1,735.78% | 13.45 17,976.03% | 4.92 63.41% | 5.57 13.23% | 3.82 31.37% | |
graham number | 0.02 - | 0.47 1,903.97% | 26.82 5,628.44% | 20.37 24.06% | 23.13 13.58% | 18.95 18.06% | |
income quality | 1.04 - | 0.56 46.21% | 0.79 40.58% | 0.75 4.50% | 0.86 14.58% | 0.90 3.61% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | |
interest coverage | |||||||
interest debt per share | 0.02 - | ||||||
inventory turnover | |||||||
invested capital | 0.00 - | ||||||
market cap | 618.48M - | 618.48M 0% | 354.24M 42.72% | 344.43M 2.77% | 896.45M 160.27% | 630.18M 29.70% | |
net current asset value | 111K - | 2.27M 1,944.14% | 195.43M 8,513.22% | 121.13M 38.02% | 157.40M 29.94% | 128.13M 18.60% | |
net debt to ebitda | 0.87 - | 0.84 3.54% | 6.05 618.58% | 1.57 74.08% | 1.60 2.01% | 1.21 24.61% | |
net income per share | -0.01 - | -0.11 1,852.53% | -2.31 1,914.28% | -3.64 57.37% | -4.05 11.31% | -3.85 4.90% | |
operating cash flow per share | -0.01 - | -0.06 950.30% | -1.82 2,731.65% | -2.74 50.30% | -3.50 27.54% | -3.45 1.47% | |
payables turnover | |||||||
receivables turnover | |||||||
research and ddevelopement to revenue | |||||||
return on tangible assets | -1.13 - | -1.07 5.12% | -0.16 84.97% | -0.62 287.50% | -0.59 5.02% | -0.75 27.08% | |
revenue per share | |||||||
roe | -1.42 - | -1.35 5.07% | -0.17 87.64% | -0.72 329.38% | -0.69 3.96% | -0.93 34.70% | |
roic | 0.96 - | 1.07 11.52% | 0.17 84.44% | 0.62 273.53% | 0.61 1.36% | 0.79 29.40% | |
sales general and administrative to revenue | |||||||
shareholders equity per share | 0.00 - | 0.08 1,956.76% | 13.83 16,191.21% | 5.07 63.35% | 5.88 15.90% | 4.15 29.40% | |
stock based compensation to revenue | |||||||
tangible asset value | 111K - | 2.28M 1,956.76% | 195.98M 8,484.41% | 124.00M 36.73% | 162.30M 30.88% | 136.15M 16.12% | |
tangible book value per share | 0.00 - | 0.08 1,956.76% | 13.83 16,191.21% | 5.07 63.35% | 5.88 15.90% | 4.15 29.40% | |
working capital | 111K - | 2.27M 1,944.14% | 195.43M 8,513.22% | 121.59M 37.78% | 159.15M 30.89% | 132.80M 16.56% |
All numbers in USD (except ratios and percentages)